Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jan 29;11(2):180.
doi: 10.3390/antibiotics11020180.

The Effects of Hemoadsorption on the Kinetics of Antibacterial and Antifungal Agents

Giorgio Berlot  1 , Stefano Di Bella  2 , Ariella Tomasini  1 , Erik Roman-Pognuz  1
Affiliations
Review

The Effects of Hemoadsorption on the Kinetics of Antibacterial and Antifungal Agents

Giorgio Berlot et al. Antibiotics (Basel). .

Abstract

The extracorporeal elimination of a pathogen or damage-associated molecular pattern via blood purification techniques is increasingly being used in patients with septic shock and other clinical conditions characterized by a life-threatening inflammatory response. The removal of these substances can be accomoplished by means of ultrafiltration or hemoadsorption. Independently from the blood putification technique used, they could also affect the clearance of antibacterial and antifungal agents with a potentially significant clinical impact. In our review, we describe the basic principles of ultrafiltration and hemoadsorption, the available devices for this latter and the existing experimental and clinical studies; the final paragraph is dedicated to practical considerations that can help clinicians to consider the clearance of antibiotics and antifungals attributable to these techniques to minimize the risk of a iatrogenic underdosage.

Keywords: antibiotics; hemoadsorption; mediators; septic shock.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Chousterman B.G., Swirski F.K., Weber G.F. Cytokine Storm and Sepsis Disease Pathogenesis. Semin. Immunopathol. 2017;39:517–528. doi: 10.1007/s00281-017-0639-8. - DOI - PubMed
    1. Evans L., Rhodes A., Alhazzani W., Antonelli M., Coopersmith C.M., French C., Machado F.R., Mcintyre L., Ostermann M., Prescott H.C., et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Crit. Care Med. 2021;49:e1063–e1143. doi: 10.1097/CCM.0000000000005337. - DOI - PubMed
    1. Ankawi G., Neri M., Zhang J., Breglia A., Ricci Z., Ronco C. Extracorporeal Techniques for the Treatment of Critically Ill Patients with Sepsis beyond Conventional Blood Purification Therapy: The Promises and the Pitfalls. Crit. Care. 2018;22:262. doi: 10.1186/s13054-018-2181-z. - DOI - PMC - PubMed
    1. Monard C., Rimmelé T., Ronco C. Extracorporeal Blood Purification Therapies for Sepsis. Blood Purif. 2019;47((Suppl. S3)):1–14. doi: 10.1159/000499520. - DOI - PubMed
    1. Rimmelé T., Kellum J.A. Clinical Review: Blood Purification for Sepsis. Crit. Care. 2011;15:205. doi: 10.1186/cc9411. - DOI - PMC - PubMed

LinkOut - more resources